Fosun-backed Gland Pharma launches $876m Indian IPO
Gland Pharma, a subsidiary of Chinese conglomerate Shanghai Fosun Pharmaceutical Group, has started bookbuilding for its Indian IPO, set to be the largest pharmaceutical listing in the country.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: